Try our mobile app

Published: 2022-08-04 00:00:00 ET
<<<  go to SBH company page
HTTP/1.1 200 OK HTTP/1.1 200 OK X-Crawlera-Slave: 181.215.99.40:3128 X-Crawlera-Version: 1.60.1 accept-ranges: bytes content-type: text/html last-modified: Thu, 04 Aug 2022 20:50:40 GMT server: AmazonS3 x-amz-id-2: iqB42Hi0mMU+S+WzBGPrKoG4AFeuU5PgvJg03Nfu+c3FBbcF3WaVu4AZZS8YPKukZMxgBvTVFwI= x-amz-meta-mode: 33188 x-amz-meta-s3cmd-attrs: uid:504/gname:fitrprnt/uname:fitrprnt/gid:504/mode:33184/mtime:1659646231/atime:1659646231/md5:c16264d11f130e9149ac8b960ebfe5f5/ctime:1659646232 x-amz-replication-status: COMPLETED x-amz-request-id: RT3YT265BGDAGTM3 x-amz-version-id: dxSIy0h2OottJFV.J2Uq2a..zl0ZjyhQ x-content-type-options: nosniff x-frame-options: SAMEORIGIN x-xss-protection: 1; mode=block x-akamai-transformed: 9 - 0 pmb=mTOE,2 expires: Thu, 06 Apr 2023 02:21:24 GMT cache-control: max-age=0, no-cache, no-store pragma: no-cache date: Thu, 06 Apr 2023 02:21:24 GMT vary: Accept-Encoding akamai-x-true-ttl: -1 strict-transport-security: max-age=31536000 ; includeSubDomains ; preload set-cookie: ak_bmsc=A810489B4FE7ACD709151B145E50D1A0~000000000000000000000000000000~YAAQRNEcuImTlxOHAQAAwWBeVBPyr3mlUe4KO/LDEXgWNDWkXRE/WbCtN0EBJq4oLhf4zgGvjslr1QI6ILvUGfb1rUjvLjzNMogZWkLTX0j1+2bSs0U7MFp8T3XjGDOgEIkZdWcyYUtdG0noYFCg0SySVuoUWgKW0E01Y2YvSm4fS169Az/OPXJQKg6MCXIACgkl1tztAMn7e6ME3NshvgW6FmoaRxLdAdI06eXvs8Wp2qDXeozSwMVLenMRcrYRD2iJXSfP2WnYdMft+bgrxBmM0bR5WAsMOu/T+tTr2VDYnru8AquReVbwlsquWSQQtlbcBFchxoVKpPQR3FRZgoMCqS7QBe6kIvZZpUFFcXlNqTZ2mM9TbIoHVVLe04ezfzkiGgMmXg==; Domain=.sec.gov; Path=/; Expires=Thu, 06 Apr 2023 04:21:23 GMT; Max-Age=7199; HttpOnly set-cookie: bm_mi=22AFD055A7D9E8D90A09CC26ABE79CC0~YAAQRNEcuIqTlxOHAQAAwWBeVBOWbVvVQ4mvxf04vTN5OnBP28rNEVqwxJcU7dpafDUL/9/ElwXHCA1T07WjI1R9dsByxqjRiddfrksQVoTazIkyRcrMgHdz7238gOh1/ki1siOpmi3HBQoc/oCU4GqhMwYeD4sHXOALjv7x30mPN/Qofu3qXZbGy7qMwVVacNIVrm+509lsp4nenJR4qHd2rX3r6DXJWhnZ55ibuBx0GvybKZ2SlawWg/yLh1s6Dc2xHw5bJ94c42gEfShLLbNfYC4XGNuP68sUdEed32kPmvEEk45myHJkeTLkChu4rfbncw1A8+jjco7sGVRqLBE/OGW4YUEjQYRWrDBY8LoXX9KwHXrWaDziDpkZ32yKUuYtsUyhQ7im1FtgBwI=~1; Domain=.sec.gov; Path=/; Expires=Thu, 06 Apr 2023 02:21:24 GMT; Max-Age=0; Secure Transfer-Encoding: chunked Proxy-Connection: close Connection: close sbh-10q_20220630.htm
0001368458 false --09-30 2022 Q3 P4Y 0001368458 2021-10-01 2022-06-30 xbrli:shares 0001368458 2022-07-29 iso4217:USD 0001368458 2022-06-30 0001368458 2021-09-30 iso4217:USD xbrli:shares 0001368458 2022-04-01 2022-06-30 0001368458 2021-04-01 2021-06-30 0001368458 2020-10-01 2021-06-30 0001368458 us-gaap:CommonStockMember 2021-09-30 0001368458 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001368458 us-gaap:RetainedEarningsMember 2021-09-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001368458 us-gaap:RetainedEarningsMember 2021-10-01 2021-12-31 0001368458 2021-10-01 2021-12-31 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-10-01 2021-12-31 0001368458 us-gaap:AdditionalPaidInCapitalMember 2021-10-01 2021-12-31 0001368458 us-gaap:CommonStockMember 2021-10-01 2021-12-31 0001368458 us-gaap:CommonStockMember 2021-12-31 0001368458 us-gaap:RetainedEarningsMember 2021-12-31 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001368458 2021-12-31 0001368458 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001368458 2022-01-01 2022-03-31 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001368458 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001368458 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001368458 us-gaap:CommonStockMember 2022-03-31 0001368458 us-gaap:RetainedEarningsMember 2022-03-31 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001368458 2022-03-31 0001368458 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001368458 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001368458 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001368458 us-gaap:CommonStockMember 2022-06-30 0001368458 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001368458 us-gaap:RetainedEarningsMember 2022-06-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001368458 us-gaap:CommonStockMember 2020-09-30 0001368458 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001368458 us-gaap:RetainedEarningsMember 2020-09-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001368458 2020-09-30 0001368458 us-gaap:RetainedEarningsMember 2020-10-01 2020-12-31 0001368458 2020-10-01 2020-12-31 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-10-01 2020-12-31 0001368458 us-gaap:AdditionalPaidInCapitalMember 2020-10-01 2020-12-31 0001368458 us-gaap:CommonStockMember 2020-10-01 2020-12-31 0001368458 us-gaap:CommonStockMember 2020-12-31 0001368458 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001368458 us-gaap:RetainedEarningsMember 2020-12-31 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001368458 2020-12-31 0001368458 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001368458 2021-01-01 2021-03-31 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001368458 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001368458 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001368458 us-gaap:CommonStockMember 2021-03-31 0001368458 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001368458 us-gaap:RetainedEarningsMember 2021-03-31 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001368458 2021-03-31 0001368458 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001368458 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001368458 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001368458 us-gaap:CommonStockMember 2021-06-30 0001368458 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001368458 us-gaap:RetainedEarningsMember 2021-06-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001368458 2021-06-30 0001368458 us-gaap:ForeignExchangeContractMember 2021-10-01 2022-06-30 sbh:segment 0001368458 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherCurrentAssetsMember 2022-06-30 0001368458 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherAssetsMember 2022-06-30 0001368458 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:OtherAssetsMember 2021-09-30 0001368458 us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001368458 us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001368458 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:AccruedLiabilitiesMember 2022-06-30 0001368458 us-gaap:SeniorNotesMember us-gaap:FairValueInputsLevel1Member 2022-06-30 0001368458 us-gaap:SeniorNotesMember us-gaap:FairValueInputsLevel1Member 2021-09-30 0001368458 sbh:TermLoanBMember us-gaap:FairValueInputsLevel2Member 2022-06-30 0001368458 sbh:TermLoanBMember us-gaap:FairValueInputsLevel2Member 2021-09-30 0001368458 sbh:ShareRepurchaseProgram2017Member 2017-08-31 0001368458 sbh:ShareRepurchaseProgram2017Member 2021-07-01 2021-07-31 0001368458 sbh:ShareRepurchaseProgram2017Member 2022-06-30 0001368458 us-gaap:AccumulatedTranslationAdjustmentMember 2021-09-30 0001368458 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-09-30 0001368458 sbh:AccumulatedForeignExchangeContractsMember 2021-09-30 0001368458 us-gaap:AccumulatedTranslationAdjustmentMember 2021-10-01 2022-06-30 0001368458 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-10-01 2022-06-30 0001368458 sbh:AccumulatedForeignExchangeContractsMember 2021-10-01 2022-06-30 0001368458 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-10-01 2022-06-30 0001368458 us-gaap:AccumulatedTranslationAdjustmentMember 2022-06-30 0001368458 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-06-30 0001368458 sbh:AccumulatedForeignExchangeContractsMember 2022-06-30 0001368458 sbh:SeniorSecuredSecondLienNotesDue2025Member sbh:SallyHoldingsAndSallyCapitalMember 2022-05-31 xbrli:pure 0001368458 sbh:SeniorSecuredSecondLienNotesDue2025Member sbh:SallyHoldingsAndSallyCapitalMember 2022-05-31 2022-05-31 0001368458 sbh:SeniorSecuredSecondLienNotesDue2025Member 2022-05-31 0001368458 sbh:SeniorSecuredSecondLienNotesDue2025Member us-gaap:LineOfCreditMember 2022-05-31 2022-05-31 0001368458 sbh:SeniorSecuredSecondLienNotesDue2025Member us-gaap:InterestExpenseMember 2022-05-31 2022-05-31 0001368458 sbh:SeniorSecuredSecondLienNotesDue2025Member 2022-05-31 2022-05-31 0001368458 us-gaap:LineOfCreditMember 2022-06-30 sbh:instrument 0001368458 currency:MXN 2022-06-30 0001368458 currency:EUR 2022-06-30 0001368458 currency:CAD 2022-06-30 0001368458 us-gaap:ForeignExchangeContractMember 2022-06-30 0001368458 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:ForeignExchangeContractMember 2021-10-01 2022-06-30 0001368458 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:ForeignExchangeContractMember 2020-10-01 2021-06-30 0001368458 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:ForeignExchangeContractMember 2022-06-30 0001368458 sbh:VariableRateTrancheMember us-gaap:InterestRateCapMember sbh:SallyHoldingsMember 2017-07-31 0001368458 sbh:VariableRateTrancheMember us-gaap:InterestRateCapMember sbh:SallyHoldingsMember 2021-10-01 2022-06-30 sbh:derivative 0001368458 sbh:TermLoanBVariableTrancheMember us-gaap:InterestRateCapMember sbh:SallyHoldingsMember 2022-06-30 0001368458 sbh:VariableRateTrancheMember us-gaap:InterestRateCapMember sbh:SallyHoldingsMember 2020-10-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember 2022-04-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember 2021-04-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember 2021-10-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember 2020-10-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember 2022-04-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember 2021-04-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember 2021-10-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember 2020-10-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:OperatingSegmentsMember 2022-04-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:OperatingSegmentsMember 2021-04-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:OperatingSegmentsMember 2021-10-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:OperatingSegmentsMember 2020-10-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:OperatingSegmentsMember 2022-04-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:OperatingSegmentsMember 2021-04-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:OperatingSegmentsMember 2021-10-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:OperatingSegmentsMember 2020-10-01 2021-06-30 0001368458 us-gaap:OperatingSegmentsMember 2022-04-01 2022-06-30 0001368458 us-gaap:OperatingSegmentsMember 2021-04-01 2021-06-30 0001368458 us-gaap:OperatingSegmentsMember 2021-10-01 2022-06-30 0001368458 us-gaap:OperatingSegmentsMember 2020-10-01 2021-06-30 0001368458 us-gaap:CorporateNonSegmentMember 2022-04-01 2022-06-30 0001368458 us-gaap:CorporateNonSegmentMember 2021-04-01 2021-06-30 0001368458 us-gaap:CorporateNonSegmentMember 2021-10-01 2022-06-30 0001368458 us-gaap:CorporateNonSegmentMember 2020-10-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:HairColorMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-04-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:HairColorMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-04-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:HairColorMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:HairColorMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-10-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:HairCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-04-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:HairCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-04-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:HairCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:HairCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-10-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:StylingToolsAndSuppliesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-04-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:StylingToolsAndSuppliesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-04-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:StylingToolsAndSuppliesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:StylingToolsAndSuppliesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-10-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:NailMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-04-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:NailMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-04-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:NailMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:NailMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-10-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:SkinAndCosmeticsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-04-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:SkinAndCosmeticsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-04-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:SkinAndCosmeticsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:SkinAndCosmeticsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-10-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:OtherBeautyItemsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-04-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:OtherBeautyItemsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-04-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:OtherBeautyItemsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember sbh:OtherBeautyItemsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-10-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-04-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-04-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-10-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:HairColorMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-04-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:HairColorMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-04-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:HairColorMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:HairColorMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-10-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:HairCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-04-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:HairCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-04-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:HairCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:HairCareMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-10-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:StylingToolsAndSuppliesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-04-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:StylingToolsAndSuppliesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-04-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:StylingToolsAndSuppliesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:StylingToolsAndSuppliesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-10-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:SkinAndCosmeticsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-04-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:SkinAndCosmeticsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-04-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:SkinAndCosmeticsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:SkinAndCosmeticsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-10-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:NailMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-04-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:NailMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-04-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:NailMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:NailMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-10-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:OtherBeautyItemsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-04-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:OtherBeautyItemsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-04-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:OtherBeautyItemsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember sbh:OtherBeautyItemsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-10-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2022-04-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-04-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2020-10-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:EntityOperatedUnitsMember us-gaap:ProductConcentrationRiskMember 2022-04-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:EntityOperatedUnitsMember us-gaap:ProductConcentrationRiskMember 2021-04-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:EntityOperatedUnitsMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:EntityOperatedUnitsMember us-gaap:ProductConcentrationRiskMember 2020-10-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember us-gaap:ProductConcentrationRiskMember 2022-04-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember us-gaap:ProductConcentrationRiskMember 2021-04-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember us-gaap:ProductConcentrationRiskMember 2020-10-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember us-gaap:FranchisedUnitsMember us-gaap:ProductConcentrationRiskMember 2022-04-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember us-gaap:FranchisedUnitsMember us-gaap:ProductConcentrationRiskMember 2021-04-01 2021-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember us-gaap:FranchisedUnitsMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-06-30 0001368458 sbh:SallyBeautySupplyMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember us-gaap:FranchisedUnitsMember us-gaap:ProductConcentrationRiskMember 2020-10-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:EntityOperatedUnitsMember us-gaap:ProductConcentrationRiskMember 2022-04-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:EntityOperatedUnitsMember us-gaap:ProductConcentrationRiskMember 2021-04-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:EntityOperatedUnitsMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:EntityOperatedUnitsMember us-gaap:ProductConcentrationRiskMember 2020-10-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:DistributorSalesConsultantsMember us-gaap:ProductConcentrationRiskMember 2022-04-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:DistributorSalesConsultantsMember us-gaap:ProductConcentrationRiskMember 2021-04-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:DistributorSalesConsultantsMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:DistributorSalesConsultantsMember us-gaap:ProductConcentrationRiskMember 2020-10-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember us-gaap:ProductConcentrationRiskMember 2022-04-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember us-gaap:ProductConcentrationRiskMember 2021-04-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember sbh:ECommerceMember us-gaap:ProductConcentrationRiskMember 2020-10-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember us-gaap:FranchisedUnitsMember us-gaap:ProductConcentrationRiskMember 2022-04-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember us-gaap:FranchisedUnitsMember us-gaap:ProductConcentrationRiskMember 2021-04-01 2021-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember us-gaap:FranchisedUnitsMember us-gaap:ProductConcentrationRiskMember 2021-10-01 2022-06-30 0001368458 sbh:BeautySystemsGroupMember us-gaap:SalesRevenueNetMember us-gaap:SalesChannelThroughIntermediaryMember us-gaap:FranchisedUnitsMember us-gaap:ProductConcentrationRiskMember 2020-10-01 2021-06-30

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED: JUNE 30, 2022

-OR-

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File No. 1-33145

 

SALLY BEAUTY HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware

 

36-2257936

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

 

 

3001 Colorado Boulevard

 

 

Denton, Texas

 

76210

(Address of principal executive offices)

 

(Zip Code)

 

(940) 898-7500

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report): N/A

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading SymbolName of each exchange on which registered

Common Stock, $0.01 par valueSBHThe New York Stock Exchange

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes    No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes    No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

 

Large accelerated filer

 

Accelerated filer

Non-accelerated filer

Smaller reporting company

 

Emerging growth company

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes      No 

As of July 29, 2022, there were 107,016,939 shares of the issuer’s common stock outstanding.

 

 

 

 


 

TABLE OF CONTENTS

 

 

Page

PART I — FINANCIAL INFORMATION

 

 

 

Item 1. Financial Statements

4

 

 

Condensed Consolidated Balance Sheets

4

Condensed Consolidated Statements of Earnings

5

Condensed Consolidated Statements of Comprehensive Income

6

Condensed Consolidated Statements of Stockholders’ Equity

7

Condensed Consolidated Statements of Cash Flows

8

Notes to Condensed Consolidated Financial Statements

9

 

 

Item 2. Management’s Discussion And Analysis Of Financial Condition And Results Of Operations

15

Item 3. Quantitative And Qualitative Disclosures About Market Risk

22

Item 4. Controls And Procedures

22

 

 

PART II — OTHER INFORMATION

 

 

 

Item 1. Legal Proceedings

23

Item 1A. Risk Factors

23

Item 6. Exhibits

24

 

 


2


 

In this Quarterly Report, references to “the Company,” “Sally Beauty,” “our company,” “we,” “our,” “ours” and “us” refer to Sally Beauty Holdings, Inc. and its consolidated subsidiaries unless otherwise indicated or the context otherwise requires.

cautionary notice regarding forward-looking statements

Statements in this Quarterly Report on Form 10-Q and in the documents incorporated by reference herein which are not purely historical facts or which depend upon future events may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which we refer to as the Exchange Act. Words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” “project,” “target,” “can,” “could,” “may,” “should,” “will,” “would” or similar expressions may also identify such forward-looking statements. Forward-looking statements may relate to, among other things, the impact on our business, operations and financial results of the novel coronavirus (“COVID-19”) pandemic.

Readers are cautioned not to place undue reliance on forward-looking statements as such statements speak only as of the date they were made and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The most important factors which could cause our actual results to differ from our forward-looking statements are set forth in our description of risk factors in Item 1A contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2021, which should be read in conjunction with the forward-looking statements in this report. Forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update any forward-looking statement.

The events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than we have described. As a result, our actual results may differ materially from the results contemplated by these forward-looking statements.

 

3


 

PART I — FINANCIAL INFORMATION

Item 1.  Financial Statements.

SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(In thousands, except par value data)

 

 

 

 

June 30,

2022

 

 

September 30,

2021

 

 

 

(Unaudited)

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

101,318

 

 

$

400,959

 

Trade accounts receivable, net

 

 

31,462

 

 

 

32,623

 

Accounts receivable, other

 

 

35,911

 

 

 

33,958

 

Inventory

 

 

1,014,622

 

 

 

871,349

 

Other current assets

 

 

59,806

 

 

 

44,686

 

Total current assets

 

 

1,243,119

 

 

 

1,383,575

 

Property and equipment, net of accumulated depreciation of $808,298 at

   June 30, 2022, and $767,403 at September 30, 2021

 

 

289,814

 

 

 

307,377

 

Operating lease assets

 

 

549,493

 

 

 

537,673

 

Goodwill

 

 

533,147

 

 

 

541,209

 

Intangible assets, excluding goodwill, net of accumulated amortization of

   $40,336 at June 30, 2022, and $38,957 at September 30, 2021

 

 

50,386

 

 

 

55,532

 

Other assets

 

 

19,907

 

 

 

21,766

 

Total assets

 

$

2,685,866

 

 

$

2,847,132

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Current maturities of long-term debt

 

$

167,169

 

 

$

194

 

Accounts payable

 

 

279,359

 

 

 

291,632

 

Accrued liabilities

 

 

165,996

 

 

 

206,155

 

Current operating lease liabilities

 

 

159,452

 

 

 

156,234

 

Income taxes payable

 

 

2,985

 

 

 

10,666

 

Total current liabilities

 

 

774,961

 

 

 

664,881

 

Long-term debt

 

 

1,083,924

 

 

 

1,382,530

 

Long-term operating lease liabilities

 

 

421,072

 

 

 

404,147

 

Other liabilities

 

 

16,781

 

 

 

29,056

 

Deferred income tax liabilities, net

 

 

93,257

 

 

 

85,777

 

Total liabilities

 

 

2,389,995

 

 

 

2,566,391

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

Common stock, $0.01 par value. Authorized 500,000 shares; 107,017 and

   113,138 shares issued and 106,963 and 112,913 shares outstanding at

   June 30, 2022, and September 30, 2021, respectively

 

 

1,070

 

 

 

1,129

 

Preferred stock, $0.01 par value. Authorized 50,000 shares; none issued

 

 

 

 

 

 

Additional paid-in capital

 

 

2,339

 

 

 

17,286

 

Accumulated earnings

 

 

418,832

 

 

 

356,967

 

Accumulated other comprehensive loss, net of tax

 

 

(126,370

)

 

 

(94,641

)

Total stockholders’ equity

 

 

295,871

 

 

 

280,741

 

Total liabilities and stockholders’ equity

 

$

2,685,866

 

 

$

2,847,132

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4


 

SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Earnings

(In thousands, except per share data)

(Unaudited)

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Net sales

 

$

961,467

 

 

$

1,022,387

 

 

$

2,853,105

 

 

$

2,884,737

 

Cost of goods sold

 

 

471,259

 

 

 

507,981

 

 

 

1,397,436

 

 

 

1,432,378

 

Gross profit

 

 

490,208

 

 

 

514,406

 

 

 

1,455,669

 

 

 

1,452,359

 

Selling, general and administrative expenses

 

 

390,961

 

 

 

386,481

 

 

 

1,156,082

 

 

 

1,143,738

 

Restructuring

 

 

44

 

 

 

508

 

 

 

1,143

 

 

 

1,371

 

Operating earnings

 

 

99,203

 

 

 

127,417

 

 

 

298,444

 

 

 

307,250

 

Interest expense

 

 

35,977

 

 

 

23,452

 

 

 

76,113

 

 

 

73,313

 

Earnings before provision for income taxes

 

 

63,226

 

 

 

103,965

 

 

 

222,331

 

 

 

233,937

 

Provision for income taxes

 

 

16,659

 

 

 

27,759

 

 

 

60,117

 

 

 

62,228

 

Net earnings

 

$

46,567

 

 

$

76,206

 

 

$

162,214

 

 

$

171,709

 

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.44

 

 

$

0.68

 

 

$

1.48

 

 

$

1.52

 

Diluted

 

$

0.43

 

 

$

0.66

 

 

$

1.46

 

 

$

1.50

 

Weighted-average shares:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

106,940

 

 

 

112,739

 

 

 

109,238

 

 

 

112,605

 

Diluted

 

 

108,526

 

 

 

114,927

 

 

 

110,907

 

 

 

114,274

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

5


SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehensive Income

(In thousands)

(Unaudited)

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Net earnings

 

$

46,567

 

 

$

76,206

 

 

$

162,214

 

 

$

171,709

 

Other comprehensive (loss) income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

 

(27,384

)

 

 

6,617

 

 

 

(34,645

)

 

 

23,734

 

Interest rate caps, net of tax

 

 

2,050

 

 

 

471

 

 

 

2,328

 

 

 

646

 

Foreign exchange contracts, net of tax

 

 

432

 

 

 

(191

)

 

 

588

 

 

 

(1,211

)

Other comprehensive (loss) income, net of tax

 

 

(24,902

)

 

 

6,897

 

 

 

(31,729

)

 

 

23,169

 

Total comprehensive income

 

$

21,665

 

 

$

83,103

 

 

$

130,485

 

 

$

194,878

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

6


SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Stockholders’ Equity

(In thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

Other

 

 

Total

 

 

Common Stock

Paid-in

 

 

Accumulated

 

 

Comprehensive

 

 

Stockholders’

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Earnings

 

 

Loss

 

 

Equity

 

Balance at September 30, 2021

 

112,913

 

 

$

1,129

 

 

$

17,286

 

 

$

356,967

 

 

$

(94,641

)

 

$

280,741

 

Net earnings

 

 

 

 

 

 

 

 

 

 

68,838

 

 

 

 

 

 

68,838

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

(3,751

)

 

 

(3,751

)

Share-based compensation

 

 

 

 

 

 

 

3,958

 

 

 

 

 

 

 

 

 

3,958

 

Stock issued for equity awards

 

795

 

 

 

8

 

 

 

7,364

 

 

 

 

 

 

 

 

 

7,372

 

Employee withholding taxes paid

   related to net share settlement

 

(56

)

 

 

(1

)

 

 

(1,136

)

 

 

 

 

 

 

 

 

(1,137

)

Repurchases and cancellations of

   common stock

 

(3,675

)

 

 

(36

)

 

 

(27,472

)

 

 

(47,492

)

 

 

 

 

 

(75,000

)

Balance at December 31, 2021

 

109,977

 

 

$

1,100

 

 

$

 

 

$

378,313

 

 

$

(98,392

)

 

$

281,021

 

Net earnings

 

 

 

 

 

 

 

 

 

 

46,808

 

 

 

 

 

 

46,808

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

(3,076

)

 

 

(3,076

)

Share-based compensation

 

 

 

 

 

 

 

2,032

 

 

 

 

 

 

 

 

 

2,032

 

Stock issued for equity awards

 

111

 

 

 

1

 

 

 

423

 

 

 

 

 

 

 

 

 

424

 

Employee withholding taxes paid

   related to net share settlement

 

(1

)

 

 

 

 

 

(15

)

 

 

 

 

 

 

 

 

(15

)

Repurchases and cancellations of

   common stock

 

(3,157

)

 

 

(32

)

 

 

(2,440

)

 

 

(52,856

)

 

 

 

 

 

(55,328

)

Balance at March 31, 2022

 

106,930

 

 

$

1,069

 

 

$

 

 

$

372,265

 

 

$

(101,468

)

 

$

271,866

 

Net earnings

 

 

 

 

 

 

 

 

 

 

46,567

 

 

 

 

 

 

46,567

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

(24,902

)

 

 

(24,902

)

Share-based compensation

 

 

 

 

 

 

 

2,113

 

 

 

 

 

 

 

 

 

2,113

 

Stock issued for equity awards

 

35

 

 

 

1

 

 

 

253

 

 

 

 

 

 

 

 

 

254

 

Employee withholding taxes paid

   related to net share settlement

 

(2

)

 

 

 

 

 

(27

)

 

 

 

 

 

 

 

 

(27

)

Balance at June 30, 2022

 

106,963

 

 

$

1,070

 

 

$

2,339

 

 

$

418,832

 

 

$

(126,370

)

 

$

295,871

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

 

 

 

 

Other

 

 

 

 

Total

 

 

Common Stock

 

Paid-in

 

 

 

 

Accumulated

 

 

 

 

Comprehensive

 

 

 

 

Stockholders’

 

 

Shares

 

 

 

 

Amount

 

 

 

 

Capital

 

 

 

 

Earnings

 

 

 

 

Loss

 

 

 

 

Equity

 

Balance at September 30, 2020

 

112,405

 

 

 

 

$

1,124

 

 

 

 

$

1,913

 

 

 

 

$

117,109

 

 

 

 

$

(104,703

)

 

 

 

$

15,443

 

Net earnings

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

57,191

 

 

 

 

 

 

 

 

 

 

57,191

 

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

23,588

 

 

 

 

 

23,588

 

Share-based compensation

 

 

 

 

 

 

 

 

 

 

 

2,893

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,893

 

Stock issued for equity awards

 

158

 

 

 

 

 

2

 

 

 

 

 

(2

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Employee withholding taxes paid

   related to net share settlement

 

(25

)

 

 

 

 

(1

)

 

 

 

 

(248

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(249

)

Balance at December 31, 2020

 

112,538

 

 

 

 

$

1,125

 

 

 

 

$

4,556

 

 

 

 

$

174,300

 

 

 

 

$

(81,115

)

 

 

 

$

98,866

 

Net earnings

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

38,312

 

 

 

 

 

 

 

 

 

 

38,312

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(7,316

)

 

 

 

 

(7,316

)

Share-based compensation

 

 

 

 

 

 

 

 

 

 

 

2,648

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,648

 

Stock issued for equity awards

 

141

 

 

 

 

 

2

 

 

 

 

 

2,321

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,323

 

Balance at March 31, 2021

 

112,679

 

 

 

 

$

1,127

 

 

 

 

$

9,525

 

 

 

 

$

212,612

 

 

 

 

$

(88,431

)

 

 

 

$

134,833

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

76,206

 

 

 

 

 

 

 

 

 

 

76,206

 

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,897

 

 

 

 

 

6,897

 

Share-based compensation

 

 

 

 

 

 

 

 

 

 

 

2,617

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,617

 

Stock issued for stock options

 

101

 

 

 

 

 

1

 

 

 

 

 

1,716

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,717

 

Balance at June 30, 2021

 

112,780

 

 

 

 

$

1,128

 

 

 

 

$

13,858

 

 

 

 

$

288,818

 

 

 

 

$

(81,534

)

 

 

 

$

222,270

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

7


SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

 

 

Nine Months Ended June 30,

 

 

 

2022

 

 

2021

 

Cash Flows from Operating Activities:

 

 

 

 

 

 

 

 

Net earnings

 

$

162,214

 

 

$

171,709

 

Adjustments to reconcile net earnings to net cash provided by operating

   activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

73,361

 

 

 

78,090

 

Share-based compensation expense

 

 

8,103

 

 

 

8,158

 

Amortization of deferred financing costs

 

 

2,702

 

 

 

3,280

 

Loss on early extinguishment of debt

 

 

16,439

 

 

 

2,449

 

Loss on disposal of equipment and other property

 

 

57

 

 

 

1,638

 

Deferred income taxes

 

 

7,702

 

 

 

(998

)

Changes in (exclusive of effects of acquisitions):

 

 

 

 

 

 

 

 

Trade accounts receivable

 

 

243

 

 

 

(8,612

)

Accounts receivable, other

 

 

(3,034

)

 

 

(10,363

)

Inventory

 

 

(160,194

)

 

 

(108,317

)

Other current assets

 

 

(15,577

)

 

 

(931

)

Other assets

 

 

3,547

 

 

 

1,578

 

Operating leases, net

 

 

8,448

 

 

 

(1,595

)

Accounts payable and accrued liabilities

 

 

(34,349

)

 

 

78,250

 

Income taxes payable

 

 

(8,169

)

 

 

6,372

 

Other liabilities

 

 

(12,266

)

 

 

(2,980

)

Net cash provided by operating activities

 

 

49,227

 

 

 

217,728

 

Cash Flows from Investing Activities:

 

 

 

 

 

 

 

 

Payments for property and equipment, net of proceeds

 

 

(67,234

)

 

 

(44,888

)

Acquisitions, net of cash acquired

 

 

(665

)

 

 

(2,351

)

Net cash used by investing activities

 

 

(67,899

)

 

 

(47,239

)

Cash Flows from Financing Activities:

 

 

 

 

 

 

 

 

Proceeds from issuance of long-term debt

 

 

283,003

 

 

 

 

Repayments of long-term debt, including prepayment costs

 

 

(433,383

)

 

 

(418,986

)

Debt issuance costs

 

 

 

 

 

(1,300

)

Payments for common stock repurchased

 

 

(130,328

)

 

 

 

Proceeds from equity awards

 

 

8,050

 

 

 

4,039

 

Employee withholding taxes paid related to net share settlement of equity awards

 

 

(1,179

)

 

 

(249

)

Net cash used by financing activities

 

 

(273,837

)

 

 

(416,496

)

Effect of foreign exchange rate changes on cash and cash equivalents

 

 

(7,132

)

 

 

2,173

 

Net decrease in cash and cash equivalents

 

 

(299,641

)

 

 

(243,834

)

Cash and cash equivalents, beginning of period

 

 

400,959

 

 

 

514,151

 

Cash and cash equivalents, end of period

 

$

101,318

 

 

$

270,317

 

Supplemental Cash Flow Information:

 

 

 

 

 

 

 

 

Interest paid

 

$

75,660

 

 

$

86,293

 

Income taxes paid

 

$

73,862

 

 

$

53,764

 

Capital expenditures incurred but not paid

 

$

7,682

 

 

$

2,098

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

 


 

8


 

Sally Beauty Holdings, Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1.   Significant Accounting Policies

Business Operations

Sally Beauty Holdings is an international specialty retailer and distributor of professional beauty supplies with operations in North America, South America and Europe. We are one of the largest distributors of professional beauty supplies in the U.S. based on store count, operating under two segments, Sally Beauty Supply (“SBS”) and Beauty Systems Group (“BSG”). Our operations consist of company-operated stores, franchise stores and several e-commerce platforms. Within BSG, we also have one of the largest networks of distributor sales consultants (“DSCs”) for professional beauty products in North America, who sell directly to salons and salon professionals. SBS targets retail consumers, salons and salon professionals, while BSG targets salons and salon professionals.

Basis of Presentation

The condensed consolidated interim financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to the rules and regulations of the SEC, although we believe that the disclosures included herein are adequate for the interim period presented. These condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2021. In the opinion of management, these condensed consolidated interim financial statements reflect all adjustments that are of a normal recurring nature and which are necessary to present fairly our consolidated financial position as of June 30, 2022, and September 30, 2021, and our consolidated results of operations, consolidated comprehensive income, consolidated statements of stockholders’ equity for the three and nine months ended June 30, 2022 and 2021, and our consolidated cash flows for the nine months ended June 30, 2022 and 2021.

Principles of Consolidation

The condensed consolidated interim financial statements include all accounts of Sally Beauty Holdings, Inc. and its subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. All amounts are in U.S. Dollars.

Accounting Policies

We adhere to the same accounting policies in the preparation of our condensed consolidated interim financial statements as we do in the preparation of our full year consolidated financial statements. As permitted under GAAP, interim accounting for certain expenses, including income taxes, is based on full-year assumptions. For interim financial reporting purposes, income taxes are recorded based upon our estimated annual effective income tax.

Use of Estimates

In order to present our financial statements in conformity with GAAP, we are required to make certain estimates and assumptions that impact our interim financial statements and supplementary disclosures. These estimates may use forecasted financial information based on reasonable information available, however are subject to change in the future. Additionally, unknown future impacts of COVID-19 may impact those estimates and assumptions as well. Significant estimates and assumptions are part of our accounting for sales allowances, deferred revenue, valuation of inventory, amortization and depreciation, intangibles and goodwill, and other reserves. We believe these estimates and assumptions are reasonable; however, they are based on management’s current knowledge of events and actions, and changes in facts and circumstances may result in revised estimates and impact actual results.

Impact of COVID-19

Our operating results for the fiscal years 2022 and 2021 were adversely impacted by the COVID-19 pandemic and its effects on the global economy. Given the uncertainty around the continued effects of the COVID-19 pandemic and macro-environment, we cannot reasonably predict the effect they will have on future periods. If once again we become materially and adversely impacted, we may have to consider adjustments to our operations, inventory, liquidity, capital expenditures and accounting estimates and reserves.


9


 

 

2.   Revenue Recognition

Substantially all of our revenue is derived through the sale of merchandise at the point-of-sale. Revenue is recognized net of estimated sales returns and sales taxes. We estimate sales returns based on historical data.

Changes to our contract liabilities, which are included in accrued liabilities in our condensed consolidated balance sheets, for the periods were as follows (in thousands):

 

 

 

 

 

 

Nine Months Ended June 30,

 

 

 

 

 

 

 

2022

 

 

2021

 

Beginning Balance

 

 

 

 

 

$

16,744

 

 

$

13,947

 

Loyalty points and gift cards issued but not redeemed, net of estimated breakage

 

 

5,195

 

 

 

11,950

 

Revenue recognized from beginning liability

 

 

(8,132

)

 

 

(9,391

)

Ending Balance

 

 

 

 

 

$

13,807

 

 

$

16,506

 

See Note 10, Segment Reporting, for additional information regarding the disaggregation of our sales revenue.

3.   Fair Value Measurements

Financial instruments measured on recurring basis

Consistent with the three-level hierarchy defined in ASC Topic 820, Fair Value Measurement, as amended, we categorize our financial assets and liabilities as follows:

(in thousands)

 

Classification

 

Fair Value Hierarchy Level

 

June 30,

2022

 

 

September 30,

2021

 

Financial Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

Other current assets

 

Level 2

 

$

547

 

 

$

 

Interest rate caps

 

Other assets

 

Level 2

 

 

2,029

 

 

 

35

 

Total assets

 

 

 

 

 

$

2,576

 

 

$

35

 

.

 

 

 

 

 

 

 

 

 

 

 

 

Financial Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange contracts

 

Accrued liabilities

 

Level 2

 

$

315

 

 

$

 

 

Financial instruments not measured at fair value

Carrying amounts and the related estimated fair value of our long-term debt, excluding capital lease obligations and debt issuance costs, are as follows:

 

 

 

 

June 30, 2022

 

 

September 30, 2021

 

(in thousands)

 

Fair Value Hierarchy Level

 

Carrying Value

 

 

Fair Value

 

 

Carrying Value

 

 

Fair Value

 

Long-term debt, excluding capital leases

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Senior notes

 

Level 1

 

$

679,961

 

 

$

638,313

 

 

$

979,961

 

 

$

1,019,635

 

Term loan B

 

Level 2

 

 

408,875

 

 

 

403,764

 

 

 

413,000

 

 

 

411,451

 

Total long-term debt

 

 

 

$

1,088,836

 

 

$

1,042,077

 

 

$

1,392,961

 

 

$

1,431,086

 

 

The table above excludes amounts, if any, related to our ABL facility as the balance approximates fair value due to the short-term nature of our borrowings. The fair value of the senior notes was measured using unadjusted quoted market prices. The fair value of Term Loan B was measured using quoted market prices for similar debt securities in active markets or widely accepted valuation techniques, such as discounted cash flow analyses, using observable inputs, such as market interest rates.

10


 

4.   Stockholders’ Equity

Share Repurchases

In August 2017, our Board of Directors approved a share repurchase program authorizing the Company to repurchase up to $1.0 billion of its common stock, subject to certain limitations governed by our debt agreements. In July 2021, our Board of Directors approved a term extension of the share repurchase program for the four-year period ending September 30, 2025. As of June 30, 2022, we had authorization of approximately $595.8 million of additional potential share repurchases remaining under our share repurchase program.

Information related to our shares repurchased and subsequently retired were as follows (in thousands):

 

 

Three Months Ended

June 30,

 

 

Nine Months Ended

June 30,

 

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

Number of shares repurchased

 

 

 

 

 

 

 

 

6,832

 

 

 

 

 

Total cost of share repurchased

 

$

 

 

$

 

 

$

130,328

 

 

$

 

 

Accumulated Other Comprehensive Loss

The change in accumulated other comprehensive loss (“AOCL”) was as follows (in thousands):

 

 

Foreign Currency Translation Adjustments

 

 

Interest Rate Caps

 

 

Foreign Exchange Contracts

 

 

Total

 

 

Balance at September 30, 2021

 

$

(92,154

)

 

$

(2,085

)

 

$

(402

)

 

$

(94,641

)

 

Other comprehensive loss before

    reclassification, net of tax

 

 

(34,645

)

 

 

1,073

 

 

 

400

 

 

 

(33,172

)

 

Reclassification to net earnings, net of tax

 

 

 

 

 

1,255

 

 

 

188

 

 

 

1,443

 

 

Balance at June 30, 2022

 

$

(126,799

)

 

$

243

 

 

$

186

 

 

$

(126,370

)

 

The tax impact for the changes in other comprehensive loss and the reclassifications to net earnings was not material.

5.   Weighted-Average Shares

The following table sets forth the reconciliation of basic and diluted weighted-average shares (in thousands):

 

 

Three Months Ended

June 30,

 

 

Nine Months Ended

June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Weighted-average basic shares

 

 

106,940

 

 

 

112,739

 

 

 

109,238

 

 

 

112,605

 

Dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock option and stock award programs

 

 

1,586

 

 

 

2,188

 

 

 

1,669

 

 

 

1,669

 

Weighted-average diluted shares

 

 

108,526

 

 

 

114,927

 

 

 

110,907

 

 

 

114,274

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Anti-dilutive options excluded from our computation of diluted shares

 

 

2,406

 

 

 

2,188

 

 

 

2,385

 

 

 

1,670

 

 

6. Goodwill and Intangible Assets

During our second fiscal quarter, we completed our annual assessment for impairment of goodwill and indefinite-lived intangible assets. For goodwill, we used a qualitative analysis and our actual and forecasted results are exceeding the estimates from the last quantitative test. Additionally, we considered potential triggering events and determined there were none for the three months ended June 30, 2022. No material impairment losses were recognized in the current or prior periods presented in connection with our goodwill and other intangible assets.

 

 

 

Three Months Ended

June 30,

 

 

Nine Months Ended

June 30,

 

(in thousands)

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Intangible assets amortization expense

 

$

977

 

 

$

1,648

 

 

$

3,047

 

 

$

4,956

 

 

Additionally, during the nine months ended June 30, 2022, the decreases in goodwill and other intangibles were primarily from the effects of foreign currency exchange rates of $8.3 million and $2.2 million, respectively.

11


 

7. Accrued Liabilities

Accrued liabilities consist of the following (in thousands):

 

 

June 30,

2022

 

 

September 30,

2021

 

Compensation and benefits

 

$

67,664

 

 

$

73,344

 

Deferred revenue

 

 

16,216

 

 

 

18,543

 

Rental obligations

 

 

11,187

 

 

 

10,501

 

Insurance reserves

 

 

6,098

 

 

 

5,934

 

Interest payable

 

 

3,722

 

 

 

24,101

 

Property and other taxes

 

 

2,497

 

 

 

3,853

 

Operating accruals and other

 

 

58,612

 

 

 

69,879

 

Total accrued liabilities

 

$

165,996

 

 

$

206,155

 

 

 

 

 

 

 

 

 

 

 

 

8.     Short-term Borrowings and Long-term Debt

During the three months ended June 30, 2022, we issued a notice of redemption (the “Redemption Notice”), to redeem on May 31, 2022, the entire $300 million aggregate outstanding principal amount of the 8.75% Senior Secured Second Lien Notes due 2025 (“8.75% Senior Notes”). The redemption was made pursuant to the terms of the Indenture dated April 24, 2020, at a redemption price equal to 104.375% of the principal amount of the 8.75% Senior Notes plus accrued but unpaid interest to, but not including, the redemption date. On May 31, 2022, we redeemed these 8.75% Senior Notes with excess cash on hand and $150.0 million in borrowings from our ABL facility. In connection with the redemption, we recognized a loss on the extinguishment of debt of $16.4 million within interest expense, which included a redemption premium of $13.1 million and the write-off of unamortized deferred financing costs of $3.3 million.

At June 30, 2022, our ABL facility had $167.0 million in outstanding borrowings and $314.2 million available for borrowing, including the Canadian sub-facility, subject to the conditions contained therein.

9.    Derivative Instruments and Hedging Activities

During the nine months ended June 30, 2022, we did not purchase or hold any derivative instruments for trading or speculative purposes. See Note 3, Fair Value Measurements, for the classification and fair value of our derivative instruments.

Designated Cash Flow Hedges

Foreign Currency Forwards

We regularly enter into foreign currency forwards to mitigate our exposure to exchange rate changes on inventory purchases in U.S. dollars by our foreign subsidiaries. At June 30, 2022, we held forwards, which expire ratably through September 30, 2022, with a notional amount, based upon exchange rates at June 30, 2022, as follows (in thousands):

Notional Currency

 

Notional Amount

 

Mexican Peso

 

$

6,478

 

Euro

 

 

4,084

 

Canadian Dollar

 

 

2,619

 

Total

 

$

13,181

 

 

Quarterly, the changes in fair value related to the foreign currency forwards are recorded into AOCL. As the forwards are exercised, the realized value is recognized into cost of goods sold, based on inventory turns, in our condensed consolidated statements of earnings. For the nine months ended June 30, 2022 and 2021, we recognized a loss of $0.2 million and a gain of $0.1 million, respectively. The effects of our foreign currency forwards were not material for the three months ended June 30, 2022 and 2021. Based on June 30, 2022, valuations and exchange rates, we expect to reclassify gains of approximately $1.6 million into cost of goods sold over the next 12 months.

12


 

Interest Rate Caps

In July 2017, we purchased two interest rate caps with an initial aggregate notional amount of $550 million (the “interest rate caps”) to mitigate the exposure to higher interest rates in connection with our term loan B. The interest rate caps are comprised of individual caplets that expire ratably through June 30, 2023, and are designated as cash flow hedges. Accordingly, changes in fair value of the interest rate caps are recorded quarterly, net of income tax, and are included in AOCL.  

For the nine months ended June 30, 2022 and 2021, we recognized expense of $1.3 million and $0.8 million, respectively, into interest expense on our condensed consolidated statements of earnings. The effects of our interest rate caps on our condensed consolidated statements of earnings were not material for the three months ended June 30, 2022 and 2021. Over the next 12 months, we expect to reclassify approximately $0.7 million into interest expense, which represents the original value of the expiring caplets.

 

 

 

10.   Segment Reporting

Segment data for the three and nine months ended June 30, 2022 and 2021, is as follows (in thousands):

 

 

 

Three Months Ended

June 30,

 

 

Nine Months Ended

June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Net sales:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sally Beauty Supply ("SBS")

 

$

551,725

 

 

$

602,681

 

 

$

1,639,040

 

 

$

1,693,015

 

Beauty Systems Group ("BSG")

 

 

409,742

 

 

 

419,706

 

 

 

1,214,065

 

 

 

1,191,722

 

Total

 

$

961,467

 

 

$

1,022,387

 

 

$

2,853,105

 

 

$

2,884,737

 

Earnings before provision for income taxes:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Segment operating earnings:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SBS

 

$

88,792

 

 

$

116,784

 

 

$

270,355

 

 

$

311,975

 

BSG

 

 

56,067

 

 

 

55,265

 

 

 

160,621

 

 

 

151,680

 

Segment operating earnings

 

 

144,859

 

 

 

172,049

 

 

 

430,976

 

 

 

463,655

 

Unallocated expenses

 

 

45,612

 

 

 

44,124

 

 

 

131,389

 

 

 

155,034

 

Restructuring

 

 

44

 

 

 

508

 

 

 

1,143

 

 

 

1,371

 

Consolidated operating earnings

 

 

99,203

 

 

 

127,417

 

 

 

298,444

 

 

 

307,250

 

Interest expense

 

 

35,977

 

 

 

23,452

 

 

 

76,113

 

 

 

73,313

 

Earnings before provision

   for income taxes

 

$

63,226

 

 

$

103,965

 

 

$

222,331

 

 

$

233,937

 

 

Sales between segments, which are eliminated in consolidation, were not material during the three and nine months ended June 30, 2022 and 2021.

Disaggregation of net sales by segment  

The following tables disaggregate our segment revenues by merchandise category. We have reclassified certain prior year amounts to conform to current year presentation.

 

 

Three Months Ended

June 30,

 

 

Nine Months Ended

June 30,

 

SBS

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Hair color

 

 

38.3

%

 

 

36.4

%

 

 

37.7

%

 

 

36.1

%

Hair care

 

 

23.5

%

 

 

22.1

%

 

 

23.8

%

 

 

21.6

%

Styling tools and supplies

 

 

18.8

%

 

 

21.3

%

 

 

19.4

%

 

 

22.4

%

Nail

 

 

11.3

%

 

 

10.9

%

 

 

10.8

%

 

 

10.8

%

Skin and cosmetics

 

 

7.6

%

 

 

8.5

%

 

 

7.6

%

 

 

8.4

%

Other beauty items

 

 

0.5

%

 

 

0.8

%

 

 

0.7

%

 

 

0.7

%

Total

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

 

13


 

 

 

 

Three Months Ended

June 30,

 

 

Nine Months Ended

June 30,

 

BSG

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Hair color

 

 

42.3

%

 

 

44.3

%

 

 

42.4

%

 

 

42.4

%

Hair care

 

 

40.0

%

 

 

37.2

%

 

 

39.9

%

 

 

38.4

%

Styling tools and supplies

 

 

11.4

%

 

 

11.6

%

 

 

11.2

%

 

 

11.7

%

Skin and cosmetics

 

 

3.4

%

 

 

3.7

%

 

 

3.9

%

 

 

4.1

%

Nail

 

 

2.5

%

 

 

2.7

%

 

 

2.3

%

 

 

2.9

%

Other beauty items

 

 

0.4

%

 

 

0.5

%

 

 

0.3

%

 

 

0.5

%

Total

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

The following tables disaggregate our segment revenue by sales channels:

 

 

Three Months Ended

June 30,

 

 

Nine Months Ended

June 30,

 

SBS

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Company-operated stores

 

 

94.0

%

 

 

94.2

%

 

 

94.0

%

 

 

93.7

%

E-commerce

 

 

6.0

%

 

 

5.7

%

 

 

6.0

%

 

 

6.2

%

Franchise stores

 

 

0.0

%

 

 

0.1

%

 

 

0.0

%

 

 

0.1

%

Total

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

 

 

 

Three Months Ended

June 30,

 

 

Nine Months Ended

June 30,

 

BSG

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Company-operated stores

 

 

66.6

%

 

 

69.2

%

 

 

66.9

%

 

 

69.7

%

Distributor sales consultants

 

 

13.9

%

 

 

14.1

%

 

 

13.9

%

 

 

14.0

%

E-commerce

 

 

11.6

%

 

 

8.8

%

 

 

11.8

%

 

 

8.8

%

Franchise stores

 

 

7.9

%

 

 

7.9

%

 

 

7.4

%

 

 

7.5

%

Total

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

 

14


 

 

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

This section should be read in conjunction with the information contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2021.

Executive Overview

In the third quarter of fiscal year 2022, we delivered solid gross margin growth in both segments compared to the same period last year. Additionally during the quarter, we repaid the entire $300 million dollar balance on our 8.75% Senior Notes and continued to invest for growth through many of our initiatives, despite volatile market conditions and its impact on our topline performance. With a healthy balance sheet, a strong operating infrastructure and the loyalty of our core customers, we believe we are well positioned to continue navigating the macro-environment and remain focused on our four strategic pillars: leveraging our digital platform, driving loyalty and personalization, delivering product innovation and optimizing our supply chain.

Financial Summary for the Three Months Ended June 30, 2022

 

Consolidated net sales for the three months ended June 30, 2022, decreased $60.9 million, or 6.0%, to $961.5 million, compared to the three months ended June 30, 2021. Consolidated net sales included a negative impact from changes in foreign currency exchange rates of $13.0 million;

 

Consolidated comparable sales decreased 3.6% for the three months ended June 30, 2022, compared to the three months ended June 30, 2021;

 

Consolidated gross profit for the three months ended June 30, 2022, decreased $24.2 million, or 4.7%, to $490.2 million, compared to the three months ended June 30, 2021. Gross margin increased 70 basis points to 51.0% for the three months ended June 30, 2022, compared to the three months ended June 30, 2021;

 

Consolidated operating earnings for the three months ended June 30, 2022, decreased $28.2 million, or 22.1%, to $99.2 million, compared to the three months ended June 30, 2021. Operating margin decreased 220 bps to 10.3% for the three months ended June 30, 2022, compared to the three months ended June 30, 2021;

 

For the three months ended June 30, 2022, our consolidated net earnings decreased $29.6 million, or 38.9%, to $46.6 million, compared to the three months ended June 30, 2021;

 

For the three months ended June 30, 2022, our diluted earnings per share was $0.43 compared to $0.66 for the three months ended June 30, 2021;

 

Cash provided by operations was $52.0 million for the three months ended June 30, 2022, compared to $86.2 million for the three months ended June 30, 2021; and

 

During the period, we redeemed the entire outstanding principal amount of our 8.75% Senior Notes at a redemption price equal to 104.375%. As a result, we recorded a loss on debt extinguishment of $16.4 million within interest expense on our condensed consolidated statements of earnings.

15


 

Trends Impacting Our Business

Global inflationary pressures continue to impact consumer spending behavior and the cost for products and services. Moreover, there is still volatility in the global supply chain, while freight carriers are faced with higher fuel prices. During the current quarter and fiscal year, these headwinds have resulted in lower traffic and conversion in our business and increases in certain operating costs, including inbound freight and delivery expenses. Additionally, due to general labor shortages in the U.S. during the year, especially among retail and hourly employees, we have experienced an increase in our compensation costs in order to attract and retain associates. We continue to monitor these challenges and implement measures to help mitigate their impacts, including managing our inventory levels to reduce out-of-stock items, adjusting our promotional activities, optimizing our store base and expanding our partnerships with delivery service providers. Although these initiatives have helped mitigate ongoing macro-headwinds we cannot reasonably predict the long-term effects of inflation and supply chain disruptions.

In a measure to curb inflation, the U.S. Federal Reserve has continued to increase the federal funds effective rate. In turn, these increases have raised the cost of debt borrowings. We currently have approximately $575.9 million in variable rate debt, with $408.9 million hedged with interest rate caps to help mitigate the impact of raising rates. Future increases in the federal funds effective rate could have a material adverse impact to our cost of debt, including any future changes in our debt structure.

Impact of COVID-19 on Our Business

During the fiscal year, we experienced disruptions to our business as a result of the COVID-19 pandemic and we continue to take certain actions in order to protect our customers and associates. In particular, our store operations continue to face challenges and disruptions related to COVID-19 surges and spikes in infection levels. While the situation has shown signs of stabilization, we cannot reasonably predict the effects of new variants or expect improving trends to continue. Therefore, our future performance may partially depend on impacts of COVID-19 such as decreased customer in-store traffic, temporary store closures, and continued labor and supply chain disruptions.

Refer to Item 1A. “Risk Factors” in our Form 10-K for the fiscal year ended September 30, 2021, for further discussion on the risks and uncertainties created by COVID-19.

Comparable Sales

The Company’s initiative to invest in our digital platforms support our omni-channel strategies to provide customers an enhanced shopping experience. As such, we believe that comparable sales is an appropriate performance indicator to measure our sales growth compared to the prior period. Our comparable sales include sales from stores that have been operating for 14 months or longer as of the last day of a month and e-commerce revenue. Additionally, comparable sales include sales to franchisees and full service sales. Our comparable sales excludes the effect of changes in foreign exchange rates and sales from stores relocated until 14 months after the relocation. Revenue from acquisitions are excluded from our comparable sales calculation until 14 months after the acquisition. Our calculation of comparable sales might not be the same as other retailers as the calculation varies across the retail industry.


16


 

 

Overview

Key Operating Metrics

The following table sets forth, for the periods indicated, information concerning key measures we rely on to evaluate our operating performance (dollars in thousands):

 

 

 

Three Months Ended

June 30,

 

 

Nine Months Ended

June 30,

 

 

 

2022

 

 

2021

 

 

Increase (Decrease)

 

 

2022

 

 

2021

 

 

Increase (Decrease)

 

Net sales:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SBS

 

$

551,725

 

 

$

602,681

 

 

$

(50,956

)

 

 

(8.5

)%

 

$

1,639,040

 

 

$

1,693,015

 

 

$

(53,975

)

 

 

(3.2

)%

BSG

 

 

409,742

 

 

 

419,706

 

 

 

(9,964

)

 

 

(2.4

)%

 

 

1,214,065

 

 

 

1,191,722

 

 

 

22,343

 

 

 

1.9

%

Consolidated

 

$

961,467

 

 

$

1,022,387

 

 

$

(60,920

)

 

 

(6.0

)%

 

$

2,853,105

 

 

$

2,884,737

 

 

$

(31,632

)

 

 

(1.1

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SBS

 

$

322,815

 

 

$

349,167

 

 

$

(26,352

)

 

 

(7.5

)%

 

$

960,249

 

 

$

982,139

 

 

$

(21,890

)

 

 

(2.2

)%

BSG

 

 

167,393

 

 

 

165,239

 

 

 

2,154

 

 

 

1.3

%

 

 

495,420

 

 

 

470,220

 

 

 

25,200

 

 

 

5.4

%

Consolidated

 

$

490,208

 

 

$

514,406

 

 

$

(24,198

)

 

 

(4.7

)%

 

$

1,455,669

 

 

$

1,452,359

 

 

$

3,310

 

 

 

0.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Segment gross margin:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SBS

 

 

58.5

%

 

 

57.9

%

 

60

 

 

bps

 

 

 

58.6

%

 

 

58.0

%

 

60

 

 

bps

 

BSG

 

 

40.9

%

 

 

39.4

%

 

150

 

 

bps

 

 

 

40.8

%

 

 

39.5

%

 

130

 

 

bps

 

Consolidated

 

 

51.0

%

 

 

50.3

%

 

70

 

 

bps

 

 

 

51.0

%

 

 

50.3

%

 

70

 

 

bps

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net earnings:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Segment operating earnings:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SBS

 

$

88,792

 

 

$

116,784

 

 

$

(27,992

)

 

 

(24.0

)%

 

$

270,355

 

 

$

311,975

 

 

$

(41,620

)

 

 

(13.3

)%

BSG

 

 

56,067

 

 

 

55,265

 

 

 

802

 

 

 

1.5

%

 

 

160,621

 

 

 

151,680

 

 

 

8,941

 

 

 

5.9

%

Segment operating earnings

 

 

144,859

 

 

 

172,049

 

 

 

(27,190

)

 

 

(15.8

)%

 

 

430,976

 

 

 

463,655

 

 

 

(32,679

)

 

 

(7.0

)%

Unallocated expenses and restructuring (a)

 

 

45,656

 

 

 

44,632

 

 

 

1,024

 

 

 

2.3

%

 

 

132,532

 

 

 

156,405

 

 

 

(23,873

)

 

 

(15.3

)%

Consolidated operating earnings

 

 

99,203

 

 

 

127,417

 

 

 

(28,214

)

 

 

(22.1

)%

 

 

298,444

 

 

 

307,250

 

 

 

(8,806

)

 

 

(2.9

)%

Interest expense

 

 

35,977

 

 

 

23,452

 

 

 

12,525

 

 

 

53.4

%

 

 

76,113

 

 

 

73,313

 

 

 

2,800

 

 

 

3.8

%

Earnings before provision for income taxes

 

 

63,226

 

 

 

103,965

 

 

 

(40,739

)

 

 

(39.2

)%

 

 

222,331

 

 

 

233,937

 

 

 

(11,606

)

 

 

(5.0

)%

Provision for income taxes

 

 

16,659

 

 

 

27,759

 

 

 

(11,100

)

 

 

(40.0

)%

 

 

60,117

 

 

 

62,228

 

 

 

(2,111

)

 

 

(3.4

)%

Net earnings

 

$

46,567

 

 

$

76,206

 

 

$

(29,639

)

 

 

(38.9

)%

 

$

162,214

 

 

$

171,709

 

 

$

(9,495

)

 

 

(5.5

)%

 

 

.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of stores at end-of-period (including franchises):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SBS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,468

 

 

 

3,611

 

 

 

(143

)

 

 

(4.0

)%

BSG

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,361

 

 

 

1,367

 

 

 

(6

)

 

 

(0.4

)%

Consolidated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,829

 

 

 

4,978

 

 

 

(149

)

 

 

(3.0

)%

Comparable sales growth (decline) (b):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SBS

 

 

(5.0

)%

 

 

43.1

%

 

(4,810)

 

 

bps

 

 

 

(0.5

)%

 

 

11.8

%

 

(1,235)

 

 

bps

 

BSG

 

 

(1.6

)%

 

 

43.0

%

 

(4,460)

 

 

bps

 

 

 

2.6

%

 

 

12.0

%

 

(941)

 

 

bps

 

Consolidated

 

 

(3.6

)%

 

 

43.1

%

 

(4,670)

 

 

bps

 

 

 

0.8

%

 

 

11.9

%

 

(1,110)

 

 

bps

 

 

 

(a)

Unallocated expenses consist of corporate and shared costs and are included in selling, general and administrative expenses in our condensed consolidated statements of earnings.

(b)

Our comparable sales include sales from stores that have been operating for 14 months or longer as of the last day of a month and e-commerce revenue. Additionally, our comparable sales include sales to franchisees and full service sales. Our comparable sales excludes the effect of changes in foreign exchange rates and sales from stores relocated until 14 months after the relocation. Revenue from acquisitions are excluded from our comparable sales calculation until 14 months after the acquisition. Prior to fiscal year 2022, we reported Same Store Sales. For fiscal year 2022, we are reporting Comparable Sales, which includes sales to franchisees and full service sales. We have recast prior year amounts to conform to the change. See “Comparable Sales” discussion above for further information.


17


 

 

Results of Operations

The Three Months Ended June 30, 2022, compared to the Three Months Ended June 30, 2021

Net Sales

SBS. The decrease in net sales for SBS was primarily driven by the following (in thousands):

Comparable sales

 

$

(28,522

)

Sales outside comparable sales (a)

 

 

(10,568

)

Foreign currency exchange

 

 

(11,866

)

Total

 

$

(50,956

)

 

(a)

Includes stores opened for less than 14 months, net of stores closures

The decrease in SBS’s net sales was driven by lower comparable sales, the negative impact from foreign exchange rates and the impact of closed stores. SBS’s comparable sales decrease was driven by fewer transactions as a result of lower store traffic, while the average ticket was relatively unchanged, resulting from lower average unit volume offset by higher average unit retail prices, led by our color and care categories.

BSG. The decrease in net sales for BSG was primarily driven by the following (in thousands):

Comparable sales

 

$

(6,597

)

Sales outside comparable sales (a)

 

 

(2,185

)

Foreign currency exchange

 

 

(1,182

)

Total

 

$

(9,964

)

 

(a)

Includes stores opened for less than 14 months, net of stores closures

The decrease in BSG’s net sales was primarily due to lower comparable sales, the impact of closed stores and the negative impact from the Canadian foreign exchange rate. BSG’s comparable sales was driven by fewer transactions as a result of lower store traffic, partially offset by an increase in average ticket, resulting from higher average unit retail prices, led by color, care and styling tools categories, partially offset by lower unit volume.

Gross Profit

SBS. SBS’s gross profit decreased for the three months ended June 30, 2022, as a result of a decrease in net sales, partially offset by a higher gross margin. SBS’s gross margin increased primarily as a result of an improvement in pricing leverage, partially offset by higher distribution and freight costs.

BSG. BSG’s gross profit increased for the three months ended June 30, 2022, driven by an improvement in pricing leverage, partially offset by higher distribution and freight costs.

Selling, General and Administrative Expenses

SBS. SBS’s selling, general and administrative expenses increased $1.6 million, or 0.7%, for the three months ended June 30, 2022. The increase was driven by higher compensation and compensation-related expenses of $5.4 million, resulting from higher wages within general labor markets, and higher information technology expenses of $1.2 million, partially offset by the favorable impact of foreign exchange rates of $4.6 million.

BSG. BSG’s selling, general and administrative expenses increased $1.4 million, or 1.2%, for the three months ended June 30, 2022. The increase was driven primarily by higher delivery expense of $1.3 million as a result of increased fuel prices

Unallocated. Unallocated selling, general and administrative expenses, which represent certain corporate costs that have not been charged to our reporting segments, increased $1.5 million, or 3.4%, for the three months ended June 30, 2022, primarily due to higher information technology expense.

Interest Expense

The increase in interest expense is primarily due to the repayment of our 8.75% Senior Notes, which resulted in a loss from debt extinguishment of $16.4 million from an early call premium of $13.1 million and the write-off of unamortized debt issuance costs of $3.3 million in the current quarter. This increase was partially offset by the interest savings of $2.3 million from the repayment of the 8.75% Senior Notes. See “Liquidity and Capital Resources” below for additional information.

Provision for Income Taxes

The effective tax rates were 26.3% and 26.7%, for the three months ended June 30, 2022, and 2021, respectively.

18


 

The Nine Months Ended June 30, 2022, compared to the Nine Months Ended June 30, 2021

Net Sales

SBS. The decrease in net sales for SBS was primarily driven by the following (in thousands):

Comparable sales

 

$

(7,818

)

Sales outside comparable sales (a)

 

 

(29,027

)

Foreign currency exchange

 

 

(17,130

)

Total

 

$

(53,975

)

 

(a)

Includes stores opened for less than 14 months, net of stores closures

The decrease in SBS’s net sales was driven by the impact of store closures, the negative impact of foreign exchange rates and lower comparable sales. SBS’s comparable sales were lower due to fewer transactions, impacted by lower traffic, and a lower average ticket, resulting from lower average unit volume, partially offset by higher average unit retail prices, led by our color and care categories.

BSG. The increase in net sales for BSG was primarily driven by the following (in thousands):

Comparable sales

 

$

29,797

 

Sales outside comparable sales (a)

 

 

(7,468

)

Foreign currency exchange

 

 

14

 

Total

 

$

22,343

 

 

(a)

Includes stores opened or acquired for less than 14 months, net of stores closures

The increase in BSG’s net sales was driven by higher comparable sales, partially offset by the impact of closed stores. BSG’s comparable sales increase was driven by a higher average ticket, resulting from higher average unit retail prices, led by color, care and styling tools categories, partially offset by lower average unit volume.

Gross Profit

SBS. SBS’s gross profit decreased for the nine months ended June 30, 2022, driven by a decrease in sales, partially offset by a higher gross margin. SBS’s gross margin increase was driven by improvement of pricing leverage and fewer write-downs of obsolete personal-protective equipment, partially offset by higher distribution and freight costs and an unfavorable sales mix shift between the U.S. and international markets, resulting from the closing of certain international operations in the prior year due to COVID-19.

BSG. BSG’s gross profit increased for the nine months ended June 30, 2022, driven by an increase in sales and a higher gross margin. BSG’s gross margin increase was driven by improvement of pricing leverage and fewer write-downs of personal-protective equipment during the current year, partially offset by higher distribution and freight costs.

Selling, General and Administrative Expenses

SBS. SBS’s selling, general and administrative expenses increased $19.7 million, or 2.9%, for the nine months ended June 30, 2022. The increase was driven by higher compensation and compensation-related expenses of $17.5 million, as a result of higher wages within general labor markets and store re-openings in certain international markets, and the unfavorable impact from foreign exchange rates of $7.1 million. These headwinds were partially offset by lower delivery expenses of $2.9 million, as a result of lower e-commerce sales, and lower facility costs of $2.2 million, as a result of operating fewer stores.

BSG. BSG’s selling, general and administrative expenses increased $16.3 million, or 5.1%, for the nine months ended June 30, 2022. The increase was driven by higher delivery expense of $3.8 million, depreciation and amortization of $3.5 million, advertising expense of $2.1 million, credit card fees of $1.4 million, utility expenses of $1.0 million and compensation and compensation-related expenses of $0.9 million.

Unallocated. Unallocated selling, general and administrative expenses, which represent certain corporate costs that have not been charged to our reporting segments, decreased $23.6 million, or 15.3%, for the nine months ended June 30, 2022, as a result of lower COVID-19 expenses of $26.4 million, including the impact of $31.2 million in donation expense in the prior year, partially offset by higher information technology expense of $3.4 million.  

Interest Expense

The increase in interest expense is primarily due to the repayment of our 8.75% Senior Notes, which resulted in a loss from debt extinguishment of $16.4 million during the nine months ended June 30, 2022, compared to loss from debt extinguishment of $4.3 million related to our repayment of our senior notes due 2023 and our term loan B fixed tranche during the prior period. This was partially offset by the interest savings in connection with these repayments for $10.2 million during the fiscal year. See “Liquidity and Capital Resources” below for additional information.

19


 

Provision for Income Taxes

The effective tax rates were 27.0% and 26.6%, for the nine months ended June 30, 2022 and 2021, respectively.

Liquidity and Capital Resources

Overview

Our capital structure contains a mix of debt and equity, and a substantial portion of our liquidity needs arise from our outstanding indebtedness and from funding the costs of our operations, working capital, capital expenditures, debt repayment and share repurchases. Working capital (current assets less current liabilities) decreased $250.5 million, to $468.2 million at June 30, 2022, compared to $718.7 million at September 30, 2021. This decrease was driven by the repayment of our 8.75% Senior Notes through the use of excess cash and additional borrowing on our ABL facility. Additionally, cash was further reduced by stock repurchases during the fiscal year. The decrease to working capital was partially offset by higher inventory as a result of the inflationary cost increases on our purchases and additional inventory relating to BSG's distribution partnership with Regis to service their salons account.  

At June 30, 2022, cash and cash equivalents were $101.3 million. We anticipate that existing cash balances (excluding certain amounts permanently invested in connection with foreign operations), cash expected to be generated by operations, and funds available under our ABL facility will be sufficient to fund working capital requirements, potential acquisitions, anticipated capital expenditures, including information technology upgrades and store remodels, and debt repayments over the next twelve months. We have continued to focus on reducing our debt levels and shares outstanding through repurchases, while also being proactive in maintaining our financial flexibility.

We utilize our ABL facility for the issuance of letters of credit, certain working capital and liquidity needs, and to manage normal fluctuations in our operational cash flow. In that regard, we may from time to time draw funds under the ABL facility for general corporate purposes including funding of capital expenditures, acquisitions, interest payments due on our indebtedness, paying down other debt and share repurchases. During the nine months ended June 30, 2022, the weighted average interest rate on our borrowings under the ABL facility was 2.9%. As of June 30, 2022, we had $167.0 million outstanding and $314.2 million available for borrowings under our ABL facility, subject to borrowing base limitations, as reduced by outstanding letters of credit. Amounts drawn on our ABL facility are generally paid down with cash provided by our operating activities.

Share Repurchase Programs

During the nine months ended June 30, 2022, we repurchased 6.8 million shares of our common stock for $130.3 million with existing cash balances. As of June 30, 2022, we had authorization of approximately $595.8 million of additional potential share repurchases remaining under our share repurchase program.

Cash Flows

Historically, our primary source of cash has been net funds provided by operating activities and, when necessary, borrowings under our ABL facility. Historically, the primary uses of cash have been for share repurchases, capital expenditures, repayments and servicing of long-term debt and acquisitions.

Net Cash Provided by Operating Activities

Net cash provided by operating activities during the nine months ended June 30, 2022, decreased $168.5 million to $49.2 million, compared to the nine months ended June 30, 2021. This decrease was driven by the reduction in our accrued liabilities, primarily due to the timing of personal-protective equipment donations and a lower bonus accrual, as well as higher inventory purchases compared to the nine months ended June 30, 2021.

Net Cash Used by Investing Activities

Net cash used by investing activities during the nine months ended June 30, 2022, increased $20.7 million to $67.9 million, compared to the nine months ended June 30, 2021. This was driven by additional investments in technology and store leasehold improvements.

Net Cash Used by Financing Activities

Net cash used by financing activities for the nine months ended June 30, 2022, decreased $142.7 million to $273.8 million, as a result of lower net debt repayments during the fiscal year, compared to prior fiscal year, partially offset by share repurchases during the nine months ended June 30, 2022.  

Debt and Guarantor Financial Information

At June 30, 2022, we had $1,255.8 million in debt, not including capital leases, unamortized debt issuance costs and debt discounts, in the aggregate, of $4.7 million. Our debt consisted of $680.0 million in senior notes outstanding, $408.9 million remaining on our term loan and $167.0 million in outstanding borrowings under our ABL facility. During the fiscal year, we called and redeemed our 8.75%

20


 

Senior Notes, at a redemption price equal to 104.375% of the principal amount, through a combination of excess cash and borrowings under our ABL facility.

We are currently in compliance with the agreements and instruments governing our debt, including our financial covenants.

Guarantor Financial Information

We currently have 5.625% Senior Notes due 2025 outstanding. These notes were issued by our wholly-owned subsidiaries, Sally Holdings LLC and Sally Capital Inc. (the “Issuers”), and registered with the Securities and Exchange Commission under a shelf registration statement.

The notes are unsecured debt instruments guaranteed by us and certain of our wholly-owned domestic subsidiaries (together, the “Guarantors”) and have certain restrictions on the ability to pay restrictive payments to Sally Beauty. The guarantees are joint and several, and full and unconditional. Certain other subsidiaries, including our foreign subsidiaries, do not serve as guarantors.

The following summarized consolidating financial information represents financial information for the Issuers and the Guarantors on a combined basis. All transactions and intercompany balances between these combined entities has been eliminated.

The following table presents the summarized balance sheets information for the Issuers and the Guarantors as of June 30, 2022, and September 30, 2021 (in thousands):

 

 

June 30, 2022

 

 

September 30, 2021

 

Inventory

 

$

790,561

 

 

$

662,802

 

Intercompany receivable

 

$

 

 

$

67,337

 

Current assets

 

$

920,021

 

 

$

1,069,266

 

Total assets

 

$

2,061,778

 

 

$

2,198,990

 

Intercompany payable

 

$

15,168

 

 

$

 

Current liabilities

 

$

653,989

 

 

$

422,137

 

Total liabilities

 

$

2,178,657

 

 

$

2,343,946

 

The following table presents the summarized statement of income information for nine months ended June 30, 2022 (in thousands):

Net sales

 

 

 

$

2,317,150

 

Gross profit

 

 

 

$

1,193,543

 

Earnings before provision for income taxes

 

 

 

$

184,505

 

Net Earnings

 

 

 

$

137,808

 

Contractual Obligations

There have been no material changes outside the ordinary course of our business in any of our contractual obligations since September 30, 2021, except for the repayment of our 8.75% Senior Notes and the additional ABL borrowings. In connection with these events, our contractual obligations contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2021, should be adjusted as follows (in thousands):

 

 

Payments Due by Period

 

 

 

Less than 1 year

 

 

1-3 years

 

 

3 - 5 years

 

 

More than 5 years

 

 

Total

 

Long-term debt obligations, including interest

 

$

122,186

 

 

$

(20,540

)

 

$

(339,375

)

 

$

 

 

$

(237,729

)

Off-Balance Sheet Financing Arrangements

At June 30, 2022, and September 30, 2021, we had no off-balance sheet financing arrangements other than outstanding letters of credit related to inventory purchases and self-insurance programs.

Critical Accounting Estimates

There have been no material changes to our critical accounting estimates or assumptions since September 30, 2021.

Recent Accounting Pronouncements

There have been no recent accounting pronouncements issued that will have a material impact to our business.


21


 

 

Item 3.  Quantitative and Qualitative Disclosures About Market Risk

As a multinational corporation, we are subject to certain market risks including foreign currency fluctuations, interest rates and government actions. There have been no material changes to our market risks from September 30, 2021. See our disclosures about market risks contained in Item 7A. “Quantitative and Qualitative Disclosures about Market Risk” in Part II of our Annual Report on Form 10-K for the fiscal year ended September 30, 2021.

Item 4.  Controls and Procedures

Controls Evaluation and Related CEO and CFO Certifications.   Our management, with the participation of our principal executive officer (“CEO”) and principal financial officer (“CFO”), conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2022. The controls evaluation was conducted by our Disclosure Committee, comprised of senior representatives from our finance, accounting, internal audit, and legal departments under the supervision of our CEO and CFO.

Certifications of our CEO and our CFO, which are required in accordance with Rule 13a-14 of the Exchange Act, are attached as exhibits to this Quarterly Report. This “Controls and Procedures” section includes the information concerning the controls evaluation referred to in the certifications and it should be read in conjunction with the certifications for a more complete understanding of the topics presented.

Limitations on the Effectiveness of Controls.   We do not expect that our disclosure controls and procedures will prevent all errors and all fraud. A system of controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the system are met. Because of the limitations in all such systems, no evaluation can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. Furthermore, the design of any system of controls and procedures is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how unlikely. Because of these inherent limitations in a cost-effective system of controls and procedures, misstatements or omissions due to error or fraud may occur and not be detected.

Scope of the Controls Evaluation.   The evaluation of our disclosure controls and procedures included a review of their objectives and design, our implementation of the controls and procedures and the effect of the controls and procedures on the information generated for use in this Quarterly Report. In the course of the evaluation, we sought to identify whether we had any data errors, control problems or acts of fraud and to confirm that appropriate corrective action, including process improvements, was being undertaken if needed. This type of evaluation is performed on a quarterly basis so that conclusions concerning the effectiveness of our disclosure controls and procedures can be reported in our Quarterly Reports on Form 10-Q and our Annual Reports on Form 10-K. Many of the components of our disclosure controls and procedures are also evaluated by our internal audit department, by our legal department and by personnel in our finance organization. The overall goals of these various evaluation activities are to monitor our disclosure controls and procedures on an ongoing basis and to maintain them as dynamic systems that change as conditions warrant.

Conclusions regarding Disclosure Controls.  Based on the required evaluation of our disclosure controls and procedures, our CEO and CFO have concluded that, as of June 30, 2022, we maintain disclosure controls and procedures that are effective in providing reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting.   During our most recent fiscal quarter, there have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

22


 

PART II — OTHER INFORMATION

We are involved, from time to time, in various claims and lawsuits incidental to the conduct of our business in the ordinary course. We carry insurance coverage in such amounts in excess of our self-insured retention as we believe to be reasonable under the circumstances and that may or may not cover any or all of our liabilities in respect of these matters. We do not believe that the ultimate resolution of these matters will have a material adverse impact on our consolidated financial position, cash flows or results of operations.

We are subject to a number of U.S., federal, state and local laws and regulations, as well as the laws and regulations applicable in each foreign country or jurisdiction in which we do business. These laws and regulations govern, among other things, the composition, packaging, labeling and safety of the products we sell, the methods we use to sell these products and the methods we use to import these products. We believe that we are in material compliance with such laws and regulations, although no assurance can be provided that this will remain true going forward.

Item 1A.  Risk Factors

In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors contained in Item 1A. “Risk Factors” in Part I of our Annual Report on Form 10-K for the fiscal year ended September 30, 2021, which could materially affect our business, financial condition or future results. There have been no material changes from the risk factors disclosed in such Annual Report. The risks described in such Annual Report and herein are not the only risks facing our company.

23


 

 

Item 6.  Exhibits

 

 

Exhibit No.

 

Description

 

 

 

3.1

 

Third Restated Certificate of Incorporation of Sally Beauty Holdings, Inc., dated January 30, 2014, which is incorporated herein by reference from Exhibit 3.3 to the Company’s Current Report on Form 8-K filed on January 30, 2014

 

 

 

3.2

 

Amended and Restated Bylaws of Sally Beauty Holdings, Inc., dated April 26, 2017, which is incorporated herein by reference from Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on April 28, 2017

 

 

 

10.1

 

Separation agreement between Pamela Kohn and the Company effective as of May 31, 2022*

 

 

 

22

 

List of Subsidiary Guarantors*

 

 

 

31.1

 

Rule 13a-14(a)/15d-14(a) Certification of Denise Paulonis*

 

 

 

31.2

 

Rule 13a-14(a)/15d-14(a) Certification of Marlo M. Cormier*

 

 

 

32.1

 

Section 1350 Certification of Denise Paulonis*

 

 

 

32.2

 

Section 1350 Certification of Marlo M. Cormier*

 

 

 

101

 

The following financial information from our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2022, formatted in iXBRL (Inline Extensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets; (ii) the Condensed Consolidated Statements of Earnings; (iii) the Condensed Consolidated Statements of Comprehensive Income; (iv) the Condensed Consolidated Statements of Stockholders’ Equity; (v) the Condensed Consolidated Statements of Cash Flows; and (vi) the Notes to Condensed Consolidated Financial Statements.

 

 

 

104

 

The cover page from our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2022, formatted in Inline XBRL (contained in Exhibit 101).

 

* Included herewith

24


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

 

SALLY BEAUTY HOLDINGS, INC.

 

 

 

(Registrant)

 

 

 

 

Date:  August 4, 2022

 

 

 

 

 

 

 

 

By:

 

/s/ Marlo M. Cormier

 

 

 

Marlo M. Cormier

 

 

 

Senior Vice President, Chief Financial Officer

 

 

 

For the Registrant and as its Principal Financial Officer

 

25